Deutsche Bank analyst George Hill raised the firm’s price target on UnitedHealth to $617 from $615 and keeps a Buy rating on the shares post the Q4 results. Despite uncertainties in Medicare and Medicaid on the policy front and in commercial due to the economic pressure, UnitedHealth is "prudent in the guidance and has multiple levers to pull to deliver upside," the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UNH:
- UnitedHealth expands health offerings with virtual behavioral coaching
- Unusually active option classes on open January 18th
- UnitedHealth price target lowered to $550 from $590 at UBS
- UnitedHealth price target raised to $590 from $575 at Loop Capital
- UNH Little Changed after Beating Earnings and Reaffirming Guidance